ARON STEWARD: Open Payments
NPI 1508244815 · RICHLAND, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$777 in 39 payments from 7 companies in 2025. Trend: 2023 $47 · 2024 $525 · 2025 $777
Food & beverage: $777
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 16 | $223 |
| Corcept Therapeutics | 5 | $149 |
| Xeris Pharmaceuticals, Inc. | 8 | $147 |
| Otsuka America Pharmaceutical, Inc. | 1 | $87 |
| ABBVIE INC. | 4 | $81 |
| Novo Nordisk Inc | 4 | $67 |
| Soleno Therapeutics, Inc. | 1 | $23 |
Products named: MOUNJARO, Korlym, RECORLEV, REXULTI, Wegovy, UBRELVY, VYKAT XR, QULIPTA.
Industry payments across WA — which companies pay providers there.
